| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| fezakinumab | interleukin-22 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Psoriasis[MeSHID:D011565] |
190.95 | phase 2 | unknown |
| fezakinumab | interleukin-22 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Psoriasis[MeSHID:D011565] |
190.95 | phase 2 | inhibitor |
| click here to return to the previous page | ||||||||